Neutral impactCompany
Akums Drugs and Pharmaceuticals Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018
NSE 1 hr ago·9 Oct 2026, 12:44 pm
Akums Drugs AND Pharma LAkums Drugs and Pharmaceuticals has received a certificate confirming the credit of 2,03,07,976 fully paid-up equity shares to its demat accounts. This compliance is required under SEBI's Regulation 74(5), which mandates that companies must formally acknowledge and record the transfer of shares to investors' depository accounts. The certificate serves as official proof that the shares have been successfully credited to the respective Demat accounts of the shareholders.
For investors, this is a routine administrative update rather than a significant market event. It confirms that the shareholding details are accurate and up to date with the depository participants. While this does not alter the company's fundamentals or financial performance, it ensures that investors have the necessary documentation for their records and facilitates smooth trading and settlement processes.
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Akums Drugs AND Pharma L (AKUMS).
- Category: Company.
Why it matters
A routine update for Akums Drugs AND Pharma L. Use the price and stock snapshot to gauge how the market is responding.
